Quazepam
| Quazepam | |
|---|---|
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 386.80 g/mol [1] |
| Melting point | 137.5-139 °C [1] |
| Solubility | Insoluble [1] |
| Predicted LogP | 4 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C17H11ClF4N2S |
| IUPAC name | 7-chloro-5-(2-fluorophenyl)-1-(2,2,2-trifluoroethyl)-3H-1,4-benzodiazepine-2-thione |
| SMILES | C1C(=S)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F)CC(F)(F)F |
| InChI | InChI=1S/C17H11ClF4N2S/c18-10-5-6-14-12(7-10)16(11-3-1-2-4-13(11)19)23-8-15(25)24(14)9-17(20,21)22/h1-7H,8-9H2 |
| InChIKey | IKMPWMZBZSAONZ-UHFFFAOYSA-N |
| CAS number | 36735-22-5 |
| UNII | JF8V0828ZI |
| PubChem CID | 4999 |
| Pharmacokinetics[] | |
|---|---|
| Elimination half-life | 39 hours |
| Metabolism | Liver |
| Excretion | Kidney |
| Routes of administration | By mouth |
Quazepam (also known as Doral, Selepam, Dormalin, Sch 16134, Quazepamum, Sch-16134, Quazepam civ, N05cd10, 253-179-4 or Prosedar) is a substance of the aniline and benzodiazepine class.
Chemistry
Stereochemistry []
Quazepam is achiral.
Druglikeness
Lipinski's rule of five
Quazepam matches Lipinski's rule of five.Pharmacology
ATC Classification
- nervous system (N)
- psycholeptics (N05)
- hypnotics and sedatives (N05C)
- benzodiazepine derivatives (N05CD)
- quazepam (N05CD10)
MeSH Classification
- hypnotics and sedatives (M0010885)
Mechanism of action []
Like other benzodiazepines, quazepam likely exerts its effects by potentiating the effect of gamma-aminobutyric acid (GABA) on GABA(A) receptors, the main inhibitory neurotransmitter receptors in the mammalian brain. GABA(A) receptors are a component of GABA-gated ionotropic chloride channels that produce inhibitory postsynaptic potentials - following activation by GABA, the channel undergoes a conformational change that allows the passage of chloride ions through the channel. The inhibitory potentials produced by GABA neurotransmission play an integral role in the suppression and control of epileptiform nerve firing such as that seen in epilepsy, which makes the GABA system a desirable target in the treatment of epilepsy. Benzodiazepines are positive allosteric modulators of GABA(A) function. They bind to the interface between alpha (α) and gamma (γ) subunits on the receptor, commonly referred to as the benzodiazepine binding site, and modulate the receptor such that its inhibitory response to GABA binding is dramatically increased. [1]
Interactions []
Interaction mechanisms documented in KEGG DRUG (number of interacting drugs):
| CYP3A4 | induction / metabolism / inhibition | 83 |
|---|---|---|
| GABRA1 | shared target | 33 |
| GABRA2 | shared target | 31 |
| GABRA3 | shared target | 31 |
| GABRA4 | shared target | 31 |
| GABRA5 | shared target | 31 |
| GABRA6 | shared target | 31 |
| GABRB1 | shared target | 31 |
| GABRB2 | shared target | 31 |
| GABRB3 | shared target | 31 |
| GABRD | shared target | 31 |
| GABRE | shared target | 31 |
| GABRG1 | shared target | 31 |
| GABRG2 | shared target | 31 |
| GABRG3 | shared target | 31 |
| GABRP | shared target | 31 |
| GABRQ | shared target | 31 |
| CYP2C9 | induction / metabolism / inhibition | 23 (1 contraindicated) |
Medical side effects []
10 side effects listed on drug labels in SIDER 4.1 (quazepam).
- Somnolence
- Headache
- Dizziness
- Asthenia
- Fatigue
- Dry mouth
- Dyspepsia
- Withdrawal syndrome
- Thinking abnormal
- Mental disability
Indications
- Chronic insomnia
- Insomnia
Legal status []
- Canada: Quazepam is a Schedule IV.
- United States: Quazepam is a Schedule IV under the "Controlled Substances Act".
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 4999, Quazepam. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/4999
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Quazepam. UNII: JF8V0828ZI. Global Substance Registration System. Accessed November 21, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/JF8V0828ZI
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 18:00:59 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 18:00:55 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 18:00:55 |
| gsrs | ok | 2026-11-20 18:00:55 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0015528) | 2026-11-20 18:00:55 |
| kegg | ok | 2026-11-20 18:00:57 |
| pubchem | ok | 2026-11-20 18:00:54 |
| missing (no r/tripreports posts mention it) | 2026-11-20 18:00:55 | |
| sider | ok | 2026-11-20 18:00:55 |
| structure | ok | 2026-11-20 18:00:55 |
| wikipedia | ok | 2026-11-20 18:00:55 |